{"doi":"10.5588/ijtld.23.0272","title":"Long-term follow-up of persons diagnosed with multidrug-resistant TB in Chennai, India, 2013–2020","abstract":"India has the largest number of multidrug-resistant TB (MDR-TB) cases, defined as Mycobacterium tuberculosis resistant to at least isoniazid (INH) and rifampicin (RIF).1 However, less than half of all persons with MDR-TB in India successfully complete treatment.1 Although initial end-of-treatment outcomes offer a standardised time point to assess the effect of treatment, these tend to underestimate the overall burden of unfavourable long-term outcomes among persons treated for TB.2,3 The long-term outcomes of persons diagnosed with MDR-TB in India, including the proportion with recurrent TB disease or mortality, are unknown. This analysis was conducted under programmatic conditions in a high-burden setting, with no regular check-ups after treatment. The results can be used to show the burden of recurrent illness and death following treatment, and can be used as a benchmark to measure improvement.","journal":"The International Journal of Tuberculosis and Lung Disease","year":2024,"id":455116,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":6,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9129,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2024-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1279387,"name":"M.K. Sathyanarayanan","orcid":null,"position":1,"is_corresponding":false},{"id":1279388,"name":"J. Lavanya","orcid":null,"position":2,"is_corresponding":false},{"id":781383,"name":"Jonathan P. Smith","orcid":"0000-0002-6396-9164","position":3,"is_corresponding":false},{"id":1279389,"name":"Surendran K. Shanmugam","orcid":null,"position":4,"is_corresponding":false},{"id":1279390,"name":"Sembulingam Tamilzhalagan","orcid":null,"position":5,"is_corresponding":false},{"id":1279391,"name":"A. Selvara","orcid":null,"position":6,"is_corresponding":false},{"id":1278954,"name":"Gayathri Ramesh","orcid":"0000-0002-3831-2339","position":7,"is_corresponding":false},{"id":435960,"name":"Srikanth Tripathy","orcid":"0000-0002-8363-2606","position":8,"is_corresponding":false},{"id":1279392,"name":"Sunil Khaparde","orcid":null,"position":9,"is_corresponding":false},{"id":1278955,"name":"Chia-Tung Ho","orcid":"0000-0002-6479-7552","position":10,"is_corresponding":false},{"id":1279393,"name":"Patricia J. Hall-Eidson","orcid":null,"position":11,"is_corresponding":false},{"id":603343,"name":"Uma Devi Ranganathan","orcid":"0000-0001-6103-0818","position":12,"is_corresponding":false},{"id":1279394,"name":"S.. Selvaraju","orcid":null,"position":13,"is_corresponding":false},{"id":371437,"name":"Patrick K. Moonan","orcid":"0000-0002-3550-2065","position":14,"is_corresponding":false},{"id":640991,"name":"Diya Surie","orcid":"0000-0003-3931-1423","position":0,"is_corresponding":true}],"reference_count":8,"raw_metadata":null,"created_at":"2026-07-19T02:03:17.458329Z","pmid":"38178300","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}